Researchers at Tel Aviv University in Israel have 3D-printed what they said is the first vascularized heart using a patient’s own cells and biological materials.

When couples attended smoking cessation programs together, their odds of quitting were nearly six times higher than for people who attempted to kick the habit alone, according to preliminary research presented April 12 at EuroPrevent 2019.

Domestic responsibilities put a damper on career satisfaction for proceduralist mothers more than for physician mothers in nonprocedural specialties, suggests a study published April 10 in JAMA Surgery.

Transsubclavian or transaxillary (TAx) access has become the preferred route for balloon-expandable TAVR when femoral access isn’t feasible, a new analysis found. Outcomes were generally favorable with TAx TAVR compared to other alternative access techniques, with the exception of higher stroke rates, researchers reported in JACC: Cardiovascular Interventions.

The FDA has granted a breakthrough therapy designation to a novel reversal agent for ticagrelor called PB2452, PhaseBio Pharmaceuticals announced April 8.

People diagnosed with type 2 diabetes at 40 or younger were about twice as likely to die over 5.6 years of follow-up compared to age-matched controls, according to a registry study from Sweden. But the relationship weakened substantially as the age of onset progressed, such that patients diagnosed in their 80s carried no excess mortality risk.

Endovascular thrombectomy (EVT) significantly reduced the risk of 90-day mortality in patients with acute ischemic stroke compared to medical therapy alone, according to a meta-analysis of 10 randomized trials cited in the 2018 update to American stroke guidelines.

Nursing home residents who were prescribed three or four preventive medications after myocardial infarction (MI) were 26% less likely to die within 90 days than those prescribed only one drug, researchers reported April 9 in Circulation: Cardiovascular Quality and Outcomes.